Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

CBYL

CARBYLAN THERAPEUTICS, INC. (CBYL)

Kalvista Pharmaceuticals (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CBYL
일자시간출처헤드라인심볼기업
2016/12/0106:25Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/12/0106:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/11/2407:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/11/2403:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/11/2306:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/11/2306:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/11/2206:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/11/0906:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/11/0505:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/10/2819:11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/10/2705:17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/10/0105:59Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/10/0105:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/09/2320:53PR Newswire (US)Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan...NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/09/1302:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/08/2419:02Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/08/1305:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/07/3005:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2905:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2806:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2505:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2505:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2505:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2406:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2305:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2305:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/2305:00GlobeNewswire Inc.Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed TransactionNASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/1719:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/1520:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
2016/06/1520:51Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
 검색 관련기사 보기:NASDAQ:CBYL